Recombinant Activated Factor VII: The Controversial Conundrum Regarding Its Off-Label Use

被引：14
|
作者：
Karkouti, Keyvan [1 ]
Levy, Jerrold H. [2 ]
机构：
[1] Univ Toronto, Univ Hlth Network, Toronto Gen Hosp, Dept Anesthesiol & Hlth Policy Management & Evalu, Toronto, ON M5G 2C4, Canada
[2] Emory Univ, Dept Anesthesiol, Sch Med Cardiothorac Anesthesiol & Crit Care Emor, Atlanta, GA 30322 USA
来源：
ANESTHESIA AND ANALGESIA | 2011年 / 113卷 / 04期
关键词：
CARDIAC-SURGERY; HEALTHY-SUBJECTS; REVERSAL; WARFARIN; SAFETY; RFVIIA;
D O I：
10.1213/ANE.0b013e318228c6a9
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
引用
收藏
页码：711 / 712
页数：2
相关论文
共 50 条
  • [41] Off-label use of recombinant factor VIIA for diffuse pulmonary hemorrhage in children
    Weng, T-F
    Wu, K-H W.
    Peng, C-T
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 424 - 425
  • [42] Off-label use of recombinant factor VIIA concentrates after cardiac surgery
    Despotis, G
    Avidan, M
    Lublin, DM
    ANNALS OF THORACIC SURGERY, 2005, 80 (01): : 3 - 5
  • [43] Off-Label Recombinant Factor VIIa Use in Pediatrics: a Multicenter Cohort Study
    Witmer, Char
    Lynch, Kevin G.
    Raffini, Leslie
    Shah, Samir S.
    BLOOD, 2009, 114 (22) : 227 - 227
  • [44] Cost-effectiveness of using recombinant activated factor VII as an off-label rescue treatment for critical bleeding requiring massive transfusion
    Ho, Kwok M.
    Litton, Edward
    TRANSFUSION, 2012, 52 (08) : 1696 - 1702
  • [45] Off-label use of recombinant activated factor VII in surgical and non-surgical patients at 16 Canadian hospitals from 2007 to 2010 (Canadian Registry Report)
    Karkouti, Keyvan
    Arellano, Ramiro
    Aye, Tim
    Dupuis, Jean-Yves
    Kent, Blaine
    Lee, Trevor W. R.
    Lin, Yulia
    Ralley, Fiona
    MacAdams, Charles
    Mazer, C. David
    Muirhead, Brian
    Rheault, Michel R.
    Rochon, Antoine
    Syed, Summer
    Waters, Terrence
    Wong, Bill
    CANADIAN JOURNAL OF ANESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2014, 61 (08): : 727 - 735
  • [46] Off-label use of antipsychotics: Rethinking "off-label"
    Groleger, Urban
    PSYCHIATRIA DANUBINA, 2007, 19 (04) : 350 - 353
  • [47] Experience with use of recombinant activated factor VII
    Divanon, F
    Hecquard, C
    Borel-Derlon, A
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2002, 27 (02) : 133 - 138
  • [48] Use of recombinant activated factor VII in children
    Hammer, Gregory B.
    Williams, Glyn D.
    PEDIATRIC ANESTHESIA, 2007, 17 (12) : 1123 - 1125
  • [49] The use of recombinant activated factor VII in neurosurgery
    Kapapa, Thomas
    Koenig, Kathrin
    Heissler, Hans E.
    Schatzmann, Christiane
    Tschan, Christoph A.
    Perl, Michael
    von Depka, Mario
    Zumkeller, Matthias
    Rickels, Eckhard
    SURGICAL NEUROLOGY, 2009, 71 (02): : 172 - 179
  • [50] Off-Label Use of Recombinant Factor VIIa in US Hospitals: Analysis of Hospital Records
    Logan, Aaron C.
    Yank, Veronica
    Stafford, Randall S.
    ANNALS OF INTERNAL MEDICINE, 2011, 154 (08) : 516 - 522
12345